Broadway Financial Corp \De\ (BYFC) Research & Development (2010 - 2026)

Broadway Financial Corp \De\ has reported Research & Development for 17 years, with the latest figure at $804000.0 in Q2 2026.

• On a quarterly basis, Research & Development rose 3.88% year-over-year to $804000.0 in Q2 2026; TTM through Jun 2026 was $3.3 million, a 13.99% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 8.98% from the prior year.
• Research & Development was $804000.0 for Q2 2026 at Broadway Financial Corp \De\, down from $940000.0 in the prior quarter.
• The five-year high for Research & Development was $940000.0 in Q1 2026, with the low at $569000.0 in Q4 2022.
• Average Research & Development over 5 years is $734888.9, with a median of $733500.0 recorded in 2022.
• The largest YoY upside for Research & Development was 258.92% in 2022 against a maximum downside of 74.4% in 2022.
• Over 5 years, Research & Development stood at $569000.0 in 2022, then climbed by 10.54% to $629000.0 in 2023, then climbed by 1.59% to $639000.0 in 2024, then grew by 19.41% to $763000.0 in 2025, then climbed by 5.37% to $804000.0 in 2026.
• The last three Research & Development figures came in at $804000.0 (Q2 2026), $940000.0 (Q1 2026), and $763000.0 (Q4 2025), per Business Quant data.